Atenolol treatment of paruresis.
Atenolol, a cardioselective beta blocker, was administered following unsuccessful treatment with propranolol to a male with a significant history of paruresis. During atenolol therapy, the client reported a decrease in ANS symptoms but no increase in ability to urinate in public restrooms. Rationale for use of atenolol is discussed.
Zgourides
G
G
Department of Psychology, University of Portland, Oregon 97203.
D001143:Arousal / Q000187:drug effects; D001262:Atenolol / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D011602:Psychophysiologic Disorders / Q000188:drug therapy* / Q000523:psychology; D016055:Urinary Retention / Q000188:drug therapy* / Q000523:psychology
D001262:Atenolol